Nys, M. | bioRxiv Science

bioRxiv2025

Structure of a pH-sensitive pentameric ligand-gated ion channel from the Sarcoptes scabies mite

Scabies is a skin infestation caused by the Sarcoptes scabiei mite. It produces a substantial global health burden, which is exacerbated by emerging resistance to prominent treatments, such as ivermectin. An anionic pentameric ligand-gated ion channel (pLGIC) identified in the mite, termed as SsCl, shows unique pH-sensitivity and is significantly modulated by ivermectin. Here, we use cryo-EM and electrophysiology to explore the pH-sensing mechanisms of SsCl and the impact of ivermectin on channel activity. Structures of SsCl were resolved under various pH conditions to capture a closed (pH 6.5) and desensitized (pH 9) state, alongside ivermectin-bound conformations. The desensitized structure adopts an unexpected "hourglass" conformation, suggesting the gating mechanisms may be more related to cation-selective channels. Structure-based analysis and mutagenesis highlighted extracellular histidine and glutamate residues which act as pH-sensors, revealing the protonation-dependent gating mechanism. Ivermectin binds at transmembrane subunit interfaces, stabilizing an open-pore conformation through hydrophobic interactions. Ivermectin bound-structures reveal a pH-dependent modulation, enhancing open-state prevalence at pH 9 and enabling atypical activation at pH 6.5, consistent with electrophysiological data. These structural and functional insights elucidate SsCls unique pH sensitivity and ivermectins mode of action, providing a foundation for designing next-generation therapeutics targeting this pathogen-related ion channel.

biochemistry↗

bioRxiv2023

An in vitro assay to investigate venom neurotoxin activity on muscle-type nicotinic acetylcholine receptor activation and for the discovery of toxin-inhibitory molecules

Snakebite envenoming is a neglected tropical disease that causes over 100,000 deaths annually. Envenomings result in variable pathologies, but systemic neurotoxicity is among the most serious and is currently only treated with difficult to access and variably efficacious commercial antivenoms. Venom-induced neurotoxicity is often caused by -neurotoxins antagonising the muscle-type nicotinic acetylcholine receptor (nAChR), a ligand-gated ion channel. Discovery of therapeutics targeting -neurotoxins is hampered by relying on binding assays that do not reveal restoration of receptor activity or more costly and/or lower throughput electrophysiology-based approaches. Here, we report the validation of a screening assay for nAChR activation using immortalised TE671 cells expressing the {gamma}-subunit containing muscle-type nAChR and a fluorescent dye that reports changes in cell membrane potential. Assay validation using traditional nAChR agonists and antagonists, which either activate or block ion fluxes, was consistent with previous studies. We then characterised antagonism of the nAChR by a variety of elapid snake venoms that cause muscle paralysis in snakebite victims, before defining the toxin-inhibiting activities of commercial antivenoms, and new types of snakebite therapeutic candidates, namely monoclonal antibodies, decoy receptors, and small molecules. Our findings show robust evidence of assay uniformity across 96-well plates and highlight the amenability of this approach for the future discovery of new snakebite therapeutics via screening campaigns. The described assay therefore represents a useful first-step approach for identifying -neurotoxins and their inhibitors in the context of snakebite envenoming, and it should provide wider value for studying modulators of nAChR activity from other sources.

pharmacology and toxicology↗